Not investment advice. Educational platform. See Disclaimer.
NYSE: ZBH
Zimmer Biomet Holdings, Inc.
Healthcare | Medical - Devices
$81.08-10.18 (-11.15%)as of 2026-07-15 04:53 UTC
Market Cap$16.1B
EPS (TTM)$3.55
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) is a $16.1B medical - devices company trading at $81.08 (−11.2% today) — 22.8× trailing earnings, yielding 1.18%. Figures from SEC EDGAR and market feeds; updated 2026-07-15 04:53 UTC.
52-Week Range
Low $80.08High $96.67
What Zimmer Biomet Holdings, Inc. does
Zimmer Biomet designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, trauma products, craniomaxillofacial and thoracic products, bone cement, surgical products, and integrated digital and robotic technologies for treating disorders and injuries to bones, joints and supporting soft tissues. The company was founded in 1927 and became an independent public company in 2001, later acquiring Biomet in 2015.
Summarized from Zimmer Biomet Holdings, Inc.’s SEC filings · Read the filing ↗
Zimmer Biomet Holdings, Inc. is a medical - devices company, listed on NYSE as ZBH.
What is ZBH's valuation?
ZBH trades at $81.08, 22.84× trailing earnings, 10.20× EV/EBITDA, as of 2026-07-15. It carries a 1.18% dividend yield.
When did ZBH last file with the SEC?
Zimmer Biomet Holdings, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-29. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-07-15 04:53 UTC. This page is also available as JSON at /api/data?ticker=ZBH and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ZBH and 3,500+ tickers.
